Uploaded July 2025 | Updated September 2026, 1 week ago

---

We’re joined by Jenn Krohn, MS, Associate Director of Risk-Based Quality Management at Gilead Sciences, to explore how centralized monitoring is transforming clinical trial oversight.

Curious how statistical tools, open source innovation, CRA training, and AI advancements come together? Jenn explains what it takes to detect critical data signals earlier, ensure trial integrity, and foster cross-functional collaboration in pharma through the #opensource community.

Tune in to explore both the opportunities and challenges involved. Click the episode link right above the description to watch the full video!